Hemoadsorption in the critically ill - Final results of the International CytoSorb Registry
Argitaratua izan da: | PLoS One 17(2022)10, S. e0274315 |
---|---|
Egile Nagusiak: | Hawchar, Fatime (Egilea), Tomescu, Dana (Egilea), Henzler, Dietrich (Egilea) |
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
2022
|
Gaiak: | |
Sarrera elektronikoa: | https://doi.org/10.1371/journal.pone.0274315 |
Antzeko dokumentuak: | In:
PLoS One |
Antzeko izenburuak
-
Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement
nork: Köhler, Thomas, et al.
Argitaratua: (2021) -
Hemoadsorption with CytoSorb and the early course of linezolid plasma concentration during septic shock
nork: Köhler, Thomas, et al.
Argitaratua: (2022) -
Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb-Basics, Indications and Perspectives-A Scoping Review
nork: Köhler, Thomas, et al.
Argitaratua: (2021) -
High-dose CytoSorb hemoadsorption is associated with improved survival in patients with septic shock : a retrospective cohort study
nork: Schultz, Philipp, et al.
Argitaratua: (2021) -
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry
nork: Al-Batran, Salah-Eddin, et al.
Argitaratua: (2021)